These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30262865)

  • 1. C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes.
    Balamurugan K; Mendoza-Villanueva D; Sharan S; Summers GH; Dobrolecki LE; Lewis MT; Sterneck E
    Oncogene; 2019 May; 38(20):3765-3780. PubMed ID: 30262865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer.
    Mendoza-Villanueva D; Balamurugan K; Ali HR; Kim SR; Sharan S; Johnson RC; Merchant AS; Caldas C; Landberg G; Sterneck E
    Oncogene; 2016 Dec; 35(48):6166-6176. PubMed ID: 27181204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.
    Balamurugan K; Wang JM; Tsai HH; Sharan S; Anver M; Leighty R; Sterneck E
    EMBO J; 2010 Dec; 29(24):4106-17. PubMed ID: 21076392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.
    Tang D; Sivko GS; DeWille JW
    Breast Cancer Res Treat; 2006 Jan; 95(2):161-70. PubMed ID: 16322893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
    Sivko GS; DeWille JW
    J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia Abrogates Tumor-Suppressive Activities of C/EBPδ in Pancreatic Cancer.
    Hartl L; Ten Brink MS; Aberson HL; Koster J; Zwijnenburg DA; Duitman J; Bijlsma MF; Spek CA
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.
    Sarkar TR; Sharan S; Wang J; Pawar SA; Cantwell CA; Johnson PF; Morrison DK; Wang JM; Sterneck E
    Mol Cell Biol; 2012 Jan; 32(2):320-32. PubMed ID: 22037769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4.
    Balamurugan K; Sharan S; Klarmann KD; Zhang Y; Coppola V; Summers GH; Roger T; Morrison DK; Keller JR; Sterneck E
    Nat Commun; 2013; 4():1662. PubMed ID: 23575666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PERK signaling through C/EBPδ contributes to ER stress-induced expression of immunomodulatory and tumor promoting chemokines by cancer cells.
    Sheshadri N; Poria DK; Sharan S; Hu Y; Yan C; Koparde VN; Balamurugan K; Sterneck E
    Cell Death Dis; 2021 Nov; 12(11):1038. PubMed ID: 34725321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
    Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
    J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.
    Schwab LP; Peacock DL; Majumdar D; Ingels JF; Jensen LC; Smith KD; Cushing RC; Seagroves TN
    Breast Cancer Res; 2012 Jan; 14(1):R6. PubMed ID: 22225988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C/EBP{delta} targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression.
    Pawar SA; Sarkar TR; Balamurugan K; Sharan S; Wang J; Zhang Y; Dowdy SF; Huang AM; Sterneck E
    Proc Natl Acad Sci U S A; 2010 May; 107(20):9210-5. PubMed ID: 20439707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Tumor CCAAT/Enhancer-Binding Protein Delta Potentiates Tumor Cell Extravasation and Pancreatic Cancer Metastasis Formation.
    Duitman J; Hartl L; Roelofs JJTH; Bijlsma MF; Spek CA
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C/EBP-δ regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1α.
    Min Y; Ghose S; Boelte K; Li J; Yang L; Lin PC
    Oncogene; 2011 Dec; 30(49):4901-9. PubMed ID: 21666710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
    Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
    Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEBPD Potentiates the Macrophage Inflammatory Response but CEBPD Knock-Out Macrophages Fail to Identify CEBPD-Dependent Pro-Inflammatory Transcriptional Programs.
    Spek CA; Aberson HL; Butler JM; de Vos AF; Duitman J
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
    J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
    Sanford DC; DeWille JW
    Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C/EBPδ-Slug-Lox1 axis promotes metastasis of lung adenocarcinoma via oxLDL uptake.
    Wang D; Cheng X; Li Y; Guo M; Zhao W; Qiu J; Zheng Y; Meng M; Ping X; Chen X; Wang S; Luo J; Luo Q; Ma X; Xu L
    Oncogene; 2020 Jan; 39(4):833-848. PubMed ID: 31562393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.